Why the first AI-generated drug won't exist for another decade

And and and the really, the first purely AI generated candidate, by definition, cannot come out the other end for ten well, eight to ten years.

33:18 / 33:47

people expect it to happen within two years. And and and the really, the first purely AI generated candidate, by definition, cannot come out the other end for ten well, eight to ten years. Right. It's gonna be a long time. We just don't know. Right? But, you know, I I think it's really interesting. I mean, we we do work with, you know, isomorphic labs on what we call undruggable targets. So we give them undruggable targets we've not been able to drug ourselves, we think are are interesting. They're working on drugging them using AlphaFold three,

About this clip

Novartis CEO explains the harsh reality behind AI drug discovery hype - while everyone expects breakthrough results in two years, the first purely AI-generated drug candidate won't emerge for 8-10 years. He shares how Novartis is partnering with Isomorphic Labs to tackle previously 'undruggable' targets using AlphaFold technology.

Why this clip

A pharmaceutical industry CEO provides a sobering reality check on AI drug discovery timelines, countering widespread hype with expert insight.

33:18 - 33:4729sprediction

Share

LinkedInX

More from this guest

Vasant Narasimhan

1 appearance · 6 clips

What they said next

Novartis CEO explains the radical rethink that transformed a 250-year-old pharma giant

4:55 - 31s · founder story

More from this episode

From the blog

Want clips like this for your podcast?

We find your top 5-8 clips, write the hooks, and deliver ready-to-post content. First 2 episodes are free.

Get 2 Episodes Clipped Free